Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 6.29 | 46.38 |
| PEG Ratio (TTM) | 0.16 | 113.39 |
| P/S Ratio (TTM) | 1.06 | 74.45 |
| P/B Ratio (TTM) | 1.01 | 69.92 |
| P/FCF Ratio (TTM) | 2.90 | 75.82 |
| Price to 5YR AVG Earnings Ratio | 5.25 | 10.94 |
| Price to 5YR AVG FCF Ratio | -17.82 | 47.53 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.72% | 3.92% |
| ROE (TTM) | 17.50% | 9.09% |
| Net Profit Margin (TTM) | 16.02% | 19.75% |
| ROIC 5YR AVG | 4.46% | 15.50% |
Growth (92%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 14.58% | 39.41% | 19.12% |
| Revenue | 17.27% | 31.94% | 41.54% |
| Net Income | 15.47% | 49.10% | 25.23% |
| Cash Flow | -87.18% | 264.19% | 121.26% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 26.40 | 4.78 |
| Quick Ratio (TTM) | 26.40 | 4.29 |
| D/E Ratio (TTM) | 4.61 | 0.84 |
| Interest Coverage (TTM) | 1.49 | 12.92 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 1.59 | 6.22 |
| LTL to 5YR AVG FCF | -65.30 | 7.54 |
| Shares Outstanding Growth 5YR AVG | 5.16% | 0.30% |